Daiichi row: HC stops ex-Ranbaxy promoters from selling assets till Feb 26
The court also directed the brothers and 12 others, including their family members and companies, to come up with a plan on how they seek to deposit the amount of Rs 3.5 billionArbitral award to Daiichi: SC junks Singh bros' appeal against HC verdict
The high court on January 31 order paved the way for enforcement of the 2016 arbitral award passed by the Singapore tribunal against the Singh brothers who had sold their shares in Ranbaxy to Daiichi
Ranbaxy
Manufacturing · India · 10K+ Employees
View Company Info for Free
Overview
Headquarters
plot no. 90 Sector 32, Gurgaon, Haryana,...Phone Number
+91 1245135000Website
www.ranbaxy.comRevenue
$94.3 MillionIndustry
About Ranbaxy
Is Ranbaxy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Click to see if Ranbaxy had a recent Job posting/layoffs
Check if Ranbaxy has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Ranbaxy recently announced quarterly report
Funding: Get notified immidiatlly once Ranbaxy has new funding data
Check out if Ranbaxy is spiking on competitors!
Product Launch: Get notified when Ranbaxy launches new products
Ranbaxy, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Ranbaxy
Recommended Actions
Reach out to Masked Content who joined Ranbaxy as Masked Content
Find more new buyers
Ranbaxy News & Media
Frequently Asked Questions Regarding Ranbaxy
Ranbaxy Laboratories Limited, India's largest pharmaceutical company, is an integrated, research based, international pharmaceutical company producing a wide range of quality, affordable generic medicines, trusted by healthcare professionals and patients across geographies. Ranbaxy's continued focus on R&D has resulted in several approvals in devel... Read More